SCHEMBL17247000

SCHEMBL17247000

c1ccc(-n2c3ccccc3c3cc(-c4c5ccccc5c(-c5ccc6sc7c8ccccc8c8ccccc8c7c6c5)c5ccccc45)ccc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ KMT2A Q03164 3/20 0.33
▸ PTGER4 P35408 1/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ HDAC4 P56524 1/20 0.31
▸ LIMK1 P53667 1/20 0.31
▸ IL1R1 P14778 1/20 0.31
▸ PTPN1 P18031 1/20 0.30
▸ MEN1 O00255 2/20 0.30
▸ ALDH1A1 P00352 2/20 0.30
▸ MAPT P10636 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ ALOX5 P09917 1/20 0.30
▸ JAK2 O60674 1/20 0.30
▸ JAK3 P52333 1/20 0.30
▸ POLB P06746 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ BRCA1 P38398 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17246989 0.94 KDM4E (0.38) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL17247032 0.92 KDM4E (0.43) L3MBTL1KDM4EATMKMT2APTGER4
SCHEMBL20375073 0.91 ALOX5 (0.39) L3MBTL1KDM4EATMALOX5
SCHEMBL23502270 0.88 L3MBTL1 (0.44) L3MBTL1KDM4EATMKMT2APTGER4
SCHEMBL20390242 0.87 ATM (0.41) L3MBTL1KDM4EATMKMT2APTGER4
SCHEMBL20321592 0.84 ATM (0.43) L3MBTL1KDM4EATMKMT2APTGER4
SCHEMBL23426874 0.84 KDM4E (0.43) L3MBTL1KDM4EATMKMT2APTGER4
SCHEMBL17246987 0.84 ALOX5 (0.39) KDM4EKMT2ALIMK1PTPN1MEN1
SCHEMBL17247034 0.84 KDM4E (0.38) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL17247152 0.83 KDM4E (0.42) L3MBTL1KDM4EATMKMT2APTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 — — US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 — — US disclosed
US-20180198077-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2018-07-12 — — US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 — — US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 — — US disclosed
US-9947879-B2 Anthracene derivative and organic electroluminescence element using same IDEMITSU KOSAN CO., LTD. (JP) 2018-04-17 — — US disclosed
US-9947879-B2 Anthracene derivative and organic electroluminescence element using same IDEMITSU KOSAN CO., LTD. (JP) 2018-04-17 — — US disclosed
US-20150325800-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2015-11-12 — — US disclosed
US-20150325800-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2015-11-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 L3MBTL1 1670/4885KDM4E 4144/4885ATM 3954/4885
US-20180198077-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME ANXA1, ANXA11, L1CAM L3MBTL1 1312/4885KDM4E 2262/4885ATM 1213/4885
US-20150325800-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME ANXA1, ANXA11, L1CAM L3MBTL1 1312/4885KDM4E 2262/4885ATM 1213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback